Register entry

Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.

Data as of · How to read this entry

Registered sites
1
Active NDC listings
7
Live patents
0
Countries
1
Base
China
Sites

Registered establishments

1
EstablishmentAddressRegistered forFEI / DUNS
Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.No.23, Donghai 5th Ave., Zhejiang Chemical Materials Base Linhai zone, Taizhou City, Zhejiang Province 317016, China (CHN)Active ingredient (API) manufacture3006545436421271589
Catalogue

Drug listings by form and route

7

7 active NDC listings: 7 bulk ingredient. By marketing category: BULK INGREDIENT 7.

Dosage formNDCs
powder7
RouteNDCs
Labeller name on the listingNDCs
zhejiang hisoar chuannan pharmaceutical co., ltd.7
Catalogue

Marketed products

7
BrandGeneric nameForm / routeNDC
-CLINDAMYCIN HYDROCHLORIDEpowder67321-301BULK INGREDIENT
-CLINDAMYCIN PALMITATE HYDROCHLORIDEpowder67321-304BULK INGREDIENT
-CLINDAMYCIN PHOSPHATEpowder67321-302BULK INGREDIENT
-FLORFENICOLpowder67321-568BULK INGREDIENT
-FLUNIXIN MEGLUMINEpowder67321-001BULK INGREDIENT
-METOPROLOL SUCCINATEpowder67321-509BULK INGREDIENT
-Phenylephrine HClpowder67321-100BULK INGREDIENT
Compare

Comparable companies in China

Enquiry

Common questions

Is Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. FDA approved?
Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. holds 1 FDA-registered establishment in China. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd.'s drugs manufactured?
The FDA register lists Taizhou City. Registered operations: active ingredient (API) manufacture.
What drugs does Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. make?
7 products are listed under Zhejiang Hisoar Chuannan Pharmaceutical Co., Ltd. in the openFDA NDC Directory, most often as powder. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.